Form 4: Roivant CFO's Share Disposal for Tax Obligations

Roivant Sciences CFO Richard Pulik disposed of 2,341 common shares to cover tax withholding obligations related to RSU vesting.

Summary

• Richard Pulik, Chief Financial Officer of Roivant Sciences Ltd. (ROIV), reported a transaction involving common shares.
• On September 28, 2025, Mr. Pulik disposed of 2,341 common shares at a price of $15.17 per share.
• This transaction was a 'net settlement' by the Issuer to satisfy applicable tax withholding obligations in connection with the vesting and settlement of previously granted Restricted Stock Units (RSUs).
• Following this transaction, Mr. Pulik beneficially owns 389,508 common shares directly.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction related to RSU vesting and tax withholding, which is a neutral event with no direct positive or negative implications for the company's operational performance or strategic outlook.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This filing represents a routine insider transaction related to executive compensation and tax obligations, which is common across all industries for publicly traded companies with RSU programs. It does not provide specific insights into broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a routine, pre-scheduled transaction for tax purposes and does not reflect a change in management's confidence or the company's fundamentals.
• Employees: No direct impact mentioned.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-scheduled insider transaction where the CFO disposed of shares to cover tax obligations arising from RSU vesting. Such transactions are common and do not provide new information regarding the company's financial health, operational performance, or strategic direction. Therefore, it does not warrant a change in investment recommendation, and a 'hold' stance is maintained based solely on this filing.

Keywords

Roivant Sciences, ROIV, Richard Pulik, CFO, Form 4, RSU, stock transaction, tax withholding, insider transaction